UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

The New England journal of medicine, 2012-09, Vol.367 (10), p.895-903

2012

Volltextzugriff (PDF)

Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer

Journal of clinical oncology, 2006-07, Vol.24 (19), p.3089-3094

2006

Volltextzugriff (PDF)

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study

European urology, 2014-06, Vol.65 (6), p.1058-1066

2014

Volltextzugriff (PDF)

Quality of Life After Open or Robotic Prostatectomy, Cryoablation or Brachytherapy for Localized Prostate Cancer

The Journal of urology, 2010-05, Vol.183 (5), p.1822-1829

2010

Volltextzugriff (PDF)

Boosted Decision Tree Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles Discriminates Prostate Cancer from Noncancer Patients

Clinical chemistry (Baltimore, Md.), 2002-10, Vol.48 (10), p.1835-1843

2002

Volltextzugriff (PDF)

Re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7

European urology, 2024-06, Vol.85 (6), p.e173-e174

2024

Volltextzugriff (PDF)

Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in Urine

The American journal of pathology, 2001-04, Vol.158 (4), p.1491-1502

2001

Volltextzugriff (PDF)

Treatment Options for Localized Prostate Cancer

American family physician, 2011-08, Vol.84 (4), p.413-420

2011

Volltextzugriff (PDF)

Lower Baseline Prostate-specific Antigen Is Associated With a Greater Overall Survival Benefit From Sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) Trial

Urology (Ridgewood, N.J.), 2013-06, Vol.81 (6), p.1297-1302

2013

Volltextzugriff (PDF)

Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens

The Journal of urology, 2018-11, Vol.200 (5), p.956-966

2018

Volltextzugriff (PDF)

Glycomic Characterization of Prostate-Specific Antigen and Prostatic Acid Phosphatase in Prostate Cancer and Benign Disease Seminal Plasma Fluids

Journal of proteome research, 2009-02, Vol.8 (2), p.620-630

2009

Volltextzugriff (PDF)

Oestrogen redux: will transdermal delivery rebalance the risk–benefit equation?

BJU international, 2017-05, Vol.119 (5), p.653-654

Schellhammer, Paul F.

2017

Volltextzugriff (PDF)

Laparoscopic Radical Prostatectomy: Decreasing the Learning Curve Using A Mentor Initiated Approach

The Journal of urology, 2003-06, Vol.169 (6), p.2063-2065

2003

Volltextzugriff (PDF)

Intermittent versus Continuous Androgen Deprivation in Prostate Cancer

The New England journal of medicine, 2013-04, Vol.368 (14), p.1314-1325

2013

Volltextzugriff (PDF)

Re: Should the Urologist Treat Castration Resistant Prostate Cancer? Yes/No

The Journal of urology, 2016-03, Vol.195 (3), p.803; discussion 803-803; discussion 804

Schellhammer, Paul F

2016

Volltextzugriff (PDF)

Normal, Benign, Preneoplastic, and Malignant Prostate Cells Have Distinct Protein Expression Profiles Resolved by Surface Enhanced Laser Desorption/Ionization Mass Spectrometry

Clinical cancer research, 2002-08, Vol.8 (8), p.2541-2552

2002

Volltextzugriff (PDF)

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

The New England journal of medicine, 2010-07, Vol.363 (5), p.411-422

2010

Volltextzugriff (PDF)

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

The New England journal of medicine, 2012-09, Vol.367 (10), p.895-903

2012

Volltextzugriff (PDF)

QUALITY OF LIFE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER: DIFFERENCES BASED ON TREATMENT MODALITY

The Journal of urology, 2001-09, Vol.166 (3), p.947-952

2001

Volltextzugriff (PDF)

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

Prostate cancer and prostatic diseases, 2020-09, Vol.23 (3), p.517-526

2020

Volltextzugriff (PDF)

Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

The Journal of urology, 2007-12, Vol.178 (6), p.2314-2330

2007

Volltextzugriff (PDF)

Gonadal steroids and body composition, strength, and sexual function in men

The New England journal of medicine, 2013-12, Vol.369 (25), p.2456

Schellhammer, Paul F

2013

Volltextzugriff (PDF)

Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men

The New England journal of medicine, 2013-12, Vol.369 (25), p.2455-2457

2013

Volltextzugriff (PDF)

A history of the Society of Urologic Oncology

Urologic oncology, 2021-09, Vol.39 (9), p.514-520

2021

Volltextzugriff (PDF)

Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer

Clinical cancer research, 2011-07, Vol.17 (13), p.4558-4567

2011

Volltextzugriff (PDF)

1 – 25 von 358

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(328)
Mit Volltextzugriff
(186)

Publikationsform

Sprache

Englisch
(358)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study

Quality of Life After Open or Robotic Prostatectomy, Cryoablation or Brachytherapy for Localized Prostate Cancer

Boosted Decision Tree Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles Discriminates Prostate Cancer from Noncancer Patients

Re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3–7

Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in Urine

Treatment Options for Localized Prostate Cancer

Lower Baseline Prostate-specific Antigen Is Associated With a Greater Overall Survival Benefit From Sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) Trial

Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens

Glycomic Characterization of Prostate-Specific Antigen and Prostatic Acid Phosphatase in Prostate Cancer and Benign Disease Seminal Plasma Fluids

Oestrogen redux: will transdermal delivery rebalance the risk–benefit equation?

Laparoscopic Radical Prostatectomy: Decreasing the Learning Curve Using A Mentor Initiated Approach

Intermittent versus Continuous Androgen Deprivation in Prostate Cancer

Re: Should the Urologist Treat Castration Resistant Prostate Cancer? Yes/No

Normal, Benign, Preneoplastic, and Malignant Prostate Cells Have Distinct Protein Expression Profiles Resolved by Surface Enhanced Laser Desorption/Ionization Mass Spectrometry

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

QUALITY OF LIFE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER: DIFFERENCES BASED ON TREATMENT MODALITY

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

Gonadal steroids and body composition, strength, and sexual function in men

Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men

A history of the Society of Urologic Oncology

Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer

Aktive Filter

Suchergebnisse filtern